- Home
- Applications
- alzheimer
Refine by
Alzheimer Product Applications
13 applications found
Over 50 million people globally are impacted by dementia. 25% of those over age 55 have a family history of dementia.* Tesis Labs Parkinson-Alzheimer-Dementia Panel examines 35 genes associated with an increased risk of developing neurodegenerative conditions: Parkinson’s disease, Alzheimer’s disease, Genetic disorders that cause ...
ByTesis Biosciences based in Scottsdale, ARIZONA (USA)
The trespassing of the blood brain barrier is a challenge for the treatment of central nervous diseases such as Alzheimer, Parkinson, stroke, or cancer (glioma). The endothelium shows tight junctions and specialized transporters which limits the bioavailability of drugs in the central nervous ...
ByNanovex Biotechnologies based in Llanera, SPAIN
This is a potential approach for brain diseases like Alzheimer, while reducing side effects due to unspecific tissue ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Protein-based drugs are the fastest growing class of drugs for the treatment of many diseases in humans, ranging from cancer to Alzheimer’s disease. Accurate viscosity values of proteins are essential in understanding behavior, designing delivery systems, and accurately determining particle size/hydrodynamic ...
ByRheoSense Inc based in San Ramo, CALIFORNIA (USA)
Automated MRI analyses that may help inform earlier, more accurate viewsof CNS disease, such as Alzheimer’s, Parkinson’s and multiple sclerosis. For healthcare providers on the frontlines of diagnosing and treating central nervous system disease, and for your patients, Qynapse brings groundbreaking peace of mind by providing results you can trust through its flagship solution, QyScore. ...
ByQynapse based in Paris, FRANCE
The technique provides valuable insights into the central mechanisms of action of drugs, supporting the advancement of treatments for conditions like Alzheimer's and aiding in the understanding of CNS drug ...
ByIconeus based in Paris, FRANCE
More than 5 million people in the United States and an estimated 50 million people worldwide are living with Alzheimer’s disease. More than 10 million people worldwide are living with Parkinson’s. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
When it comes to brain health, you and your loved ones deserve as much clarity and accuracy as possible. That’s why Qynapse is dedicated to providing you and your physician with an objective view of your brain health. ...
ByQynapse based in Paris, FRANCE
Our driving philosophy at Otsuka is to serve those with unmet medical needs, and that couldn’t be more true than in our dedication to the central nervous system (CNS) space. In our 30 years of experience working in this therapeutic area, we continue to innovate and defy limitation by taking risks to overcome the complexities of treating mental health. We respect the value within every mind and are committed to making a difference in the lives of patients living with schizophrenia, major depressive disorder, ...
ByOtsuka America Pharmaceutical, Inc based in Princeton, NEW JERSEY (USA)
Versatile blood research tool: Hemostasis monitoring of newly emerged anticoagulants especially during cardiac surgeries poses more and more challenges to standard diagnostic instrumentations. 3T developers have made pioneering contributions in QCM-D technology for the analysis of health-related whole blood parameters (Oberfrank et al, 2016; Sinn et al, 2011; 2010; Müller et al, 2010). Now the qCell T series provides a sophisticated platform with outstanding potential to face such challenging situations due ...
By3T Analytik GmbH & Co. KG based in Neuhausen ob Eck, GERMANY
Isolating edited-pluripotent stem cells with traditional sorting techniques can subject the cells to rough conditions in which gene expression, genomic stability and overall cell-health can become compromised. Microfluidic cell sorting with the WOLF, along with single cell deposition using the N1 single cell dispenser, eliminates the challenges that pluripotent stem cells face by sorting at gentle pressures without decompression shock and shear stress, and allow for efficient single cell deposition for high ...
ByNanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA)
As targeted therapies evolve and the limitations of antibody-based therapies become clearer, a growing number of research teams are exploring the therapeutic potential of ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)